Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Guoying Zhou

4PUBLICATIONS
4CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

Sort by Publication Date:
|Jul 03, 2026
NKG2A-HLA-E and TIM3-galectin 9 pathways promote immune inhibition and represent therapeutic vulnerabilities in pancreatic ductal adenocarcinoma.

|Nov 01, 2024
Unlocking the therapeutic potential of the NKG2A-HLA-E immune checkpoint pathway in T cells and NK cells for cancer immunotherapy.

Yan Li, Zhu Li, Yisen Tang

|May 21, 2022
Modelling immune cytotoxicity for cholangiocarcinoma with tumour-derived organoids and effector T cells.

Guoying Zhou, Ruby Lieshout, Gilles S van Tienderen

|Aug 17, 2021
Immune suppressive checkpoint interactions in the tumour microenvironment of primary liver cancers.

Guoying Zhou, Patrick P C Boor, Marco J Bruno

Pageof 1

Frequent Collaborators

1 joint publications

Ruby Lieshout

1 joint publications

Martin E van Royen

1 joint publications

Monique M A Verstegen

1 joint publications

Wanhua Feng

Frequent Collaborators

1 joint publications

Ruby Lieshout

1 joint publications

Martin E van Royen

1 joint publications

Monique M A Verstegen

1 joint publications

Wanhua Feng